VBI Vaccines to Present New Preclinical Data for its GBM Immunotherapy, VBI-1901, at The Immuno-Oncology Summit – Benzinga
|
VBI Vaccines to Present New Preclinical Data for its GBM Immunotherapy, VBI-1901, at The Immuno-Oncology Summit
Benzinga VBI-1901 is a novel immunotherapy developed using VBI’s eVLP technology to target CMV-positive (CMV+) tumors, including glioblastoma multiforme (GBM), the company’s lead immuno-oncology program. Dr. Anderson will present data in animal models … |
|
VBI Vaccines to Present New Preclinical Data for its GBM Immunotherapy, VBI-1901, at The Immuno-Oncology Summit
Marketwired (press release) VBI-1901 is a novel immunotherapy developed using VBI’s eVLP technology to target CMV-positive (CMV+) tumors, including glioblastoma multiforme (GBM), the company’s lead immuno-oncology program. Dr. Anderson will present data in animal models … |
Markets Insider |
Gilead just bought a cancer-immunotherapy company for $12 billion
Markets Insider Gilead, known for its HIV and hepatitis C drugs, has been growing a cash pile over the past few years since the approval of its hepatitis C drug in 2013, leading investors to speculate what company it might buy. Gilead’s purchase of Kite is the first … Kite Soars on Sale to Gilead – Biotech MoversTheStreet.com Gilead Makes Long-Awaited Splash With $12B Bet on Kite, Cell TherapyXconomy Gilead is buying Santa Monica biotech firm Kite Pharma for $11.9 billionLos Angeles Times STLtoday.com –Proactive Investors UK all 162 news articles » |
STAT |
Gilead agrees to buy Kite Pharma, leaping into CAR–T cancer therapy
STAT With the Kite deal, Gilead becomes a player in a new type of blockbuster cancer treatment in which a patient’s own immune cells are re-engineered to recognize and kill cancer cells — a technology known as CAR–T. Kite’s lead therapy, known as axi-cel, … Gilead to Buy Kite for Promising Cancer Therapies in $12 Billion DealNew York Times Gilead to buy Kite Pharma for about $12 billionSTLtoday.com Gilead Sciences to Acquire Israeli Cancer Curing Kite Pharma for $11.9 BillionThe Jewish Press – JewishPress.com Modesto Bee all 114 news articles » |
BBC News |
TEDGlobal: The computer that can smell explosives
BBC News “We think that the processing power that is going to run the robots of the future will be synthetic biology-based and we are laying the foundations for that today.” The fusion of biology and technology gained headlines recently when Elon Musk, chief … Computer of Future which will smell explosives like dogs—TED GlobalRS-Tech (press release) (blog) |